Vertex Portfolio News
Here are the latest updates on our portfolio companies across the Vertex network. Stay connected by signing up for our monthly newsletter here.
- BigEndian Semiconductors (SEA & India) raised $3 million in a funding round led by Vertex Ventures SEA & India
- Evisort (US) to be acquired by Workday
- Kapiva (SEA & India) Secures $10 Million in Series C Round Led by OrbiMed Asia to Fuel Expansion Plans
- Own (Israel) acquired by Salesforce for $1.9 billion in cash
- Bicycle Therapeutics (Healthcare & Growth) presents updated clinical results across oncology pipeline at ESMO congress 2024
- Cyberhaven (US & Growth) Expands Leadership Team with Key Industry Executives
- EyeBio (Healthcare) and Merck announce initiation of Phase2b/3 clinical trial for Restoret for diabetic macular edema
- Elevation Oncology (Healthcare) receives fast rack designation for EO-3021
- Hasura (US) Names Cloud Software Veteran Executive Suku Krishnaraj Chief Operating Officer and President of Go-to-Market
- Harbour BioMed (China) Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
- LeaseLock (US) Names Industry Veteran John Lis as Senior Vice President of Sales
- Nium (SEA, India & Growth) Expands Across Australia and New Zealand, Driven by Increased Adoption from Financial Institutions and Spend Management Platforms
- Nium (SEA, India & Growth) Strengthens Executive Leadership Team with Chief Financial Officer and Chief Compliance Officer Appointments
- Obsidian Therapeutics (Healthcare) Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OBX-115 for the Treatment of Advanced Melanoma
- Septerna (Healthcare) Announces Initiation of Phase 1 Clinical Trial with SEP-786, a Novel Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
- Septerna (Healthcare) appoints Jae Kim joins as CMO
- Septerna (Healthcare) presents new preclinical data on PTH1R agonist for hypoparathyroidism at ASBMR 2024
- Sonoma Biotherapeutics (Healthcare) received 45m milestone payment from Regeneron
- PatSnap (SEA, India & Growth) to expand AI-powered patent search
- TORL BioTherapeutics (Healthcare) Presents Updated Phase 1 Results of Novel Claudin 6 Targeted Antibody-Drug Conjugate TORL-1-23 at the 2024 European Society of Medical Oncology Congress
- TORL BioTherapeutics (Healthcare) Announces Appointment of Howard A. "Skip" Burris III, MD, FACP, FASCO as Board Member
- Zenity (Israel) Announces AI Trust Layer, the First Agent-Less Security Solution for Microsoft 365 Copilot
- Neuspera (Healthcare) featured in MassDevice's Top 10 Urology Device Stories of the Year
You may also like...